18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer

World Journal of Surgery

Volumn 27, Issue 10, 2003, Pages 1099-1104

  Baslaim, Muna M ^a   Bakheet, M ^b   Bakheet, Razan ^b   Ezzat, Adnan ^b   El Foudeh, Mahmoud ^b   Tulbah, Asma ^b  

^a KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BONE METASTASIS; BONE TUMOR; BREAST BIOPSY; BREAST CANCER; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ERYTHEMA; FEMALE; HUMAN; INFLAMMATORY BREAST CANCER; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTITIS; METASTASIS; PAGET NIPPLE DISEASE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MASTITIS; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0141888991     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-6893-z     Document Type: Article

References (15)

1. Glass JL, Frazee RC. Inflammatory breast cancer. Am. Surg. 1995;61:121-124
2. Lopez MJ, Porter KA. Inflammatory breast cancer: special problems in breast cancer therapy. Surg. Clin. North Am. 1996;76:411-429
3. Chittoor SR, Swain SM. Locally advanced breast carcinoma: role of medical of oncology. In Bland KI, Copeland EM, editors, The Breast, Comprehensive Management of Benign and Malignant Diseases, 2nd edition, Philadelphia, Saunders, 1998;1277-1298
4. Fleming RYD, Singletary SE. Inflammatory Breast Cancer, M. D Anderson Solid Tumor Oncology Series. New York, Springer, 1999;294-305
5. Avril N, Dose J, Jônicke F, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J. Clin. Oncol. 1996;14:1848-1857
6. Jansson T, Westlin JE, Ahlström H, et al. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J. Clin. Oncol. 1995;13:1470-1477
7. Brito RA, Valero V, Buzdar AU, et al. Long term results of combined modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M. D. Anderson Cancer Center experience. J. Clin. Oncol. 2001;19:628-633
8. Smith IC, Welch AE, Hutcheon AW, et al. Positron emission tomography using [18F]-fluorodeoxy-d-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J. Clin. Oncol. 2000;18:1676-1688
9. Flanagan FL, Dehdashti F, Siegel BA. PET in breast cancer. Semin. Nucl. Med. 1998;28:290-302
10. Wahl RL, Helvie MA, Chang AE, et al. Detection of breast mass after augmentation mammoplasty using 18-fluorodeoxyglucose-PET. J. Nucl. Med. 1994;35:872
11. Wahl RL, Zasadny K, Helvie M, et al. Metabolic monitoring of breast cancer chemotherapy using positron emission tomography: initial evaluation. J. Clin. Oncol. 1993;11:2101-2111
12. Schelling M, Avril N, Nôhrig J, et al. Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J. Clin. Oncol. 2000;18:1689-1695
13. Dehdashti F, Flanagan F, Moretimer JE, et al. Positron emission tomography assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur. J. Nucl. Med. 1999;26:51-56
14. Rosen PP. Unusual Clinical Presentations of Carcinoma: Rosen's Breast Pathology, Philadelphia, Lippincott-Raven, 1997;567-595
15. Tardivon AA, Viala J, Rudelli AC, et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur. J. Radiol. 1997;24:124-130